General Information of the Compound
| Compound ID |
CP0020977
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one
1,2-dihydro-3h-benzo[f]chromen-3-one
1,2-dihydrobenzo[f]chromen-3-one
1H,2H,3H-naphtho[2,1-b]pyran-3-one
1H-benzo[f]chromen-3(2H)-one
5690-03-9
AC1L1JZ6
AC1Q6ML4
BDBM29590
BSPBio_001116
Bio2_000398
Bio2_000878
CHEBI:75272
CHEMBL86537
GTPL8101
HMS1362H17
HMS1990H17
ISFPDBUKMJDAJH-UHFFFAOYSA-N
KBio2_000456
KBio2_003024
KBio2_005592
KBio3_000851
KBio3_000852
KBioGR_000456
KBioSS_000456
MolPort-003-959-546
SCHEMBL2544804
Splitomycin
Tocris-1542
ZINC27374
splitomicin
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H10O2
|
||||||||||||||||||
| Molecular Weight |
198.221
|
||||||||||||||||||
| Canonical SMILES |
O=C1CCc2c(O1)ccc1ccccc21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H10O2/c14-13-8-6-11-10-4-2-1-3-9(10)5-7-12(11)15-13/h1-5,7H,6,8H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ISFPDBUKMJDAJH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound